1
|
Chen Y, Xing H, Wen J, Peng Q, Liu R, Sun W, Jin H, Xu K, Huang Y. Three-dimensional ultrasound imaging: An effective method to detect the effect of moderate intensity statin treatment in slowing carotid plaque progression. J Clin Ultrasound 2021; 49:731-740. [PMID: 33884633 DOI: 10.1002/jcu.23013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/14/2020] [Revised: 03/12/2021] [Accepted: 03/17/2021] [Indexed: 06/12/2023]
Abstract
PURPOSE We aimed to evaluate the feasibility of three-dimensional ultrasound imaging (3DUS) in assessing the therapeutic effect of moderate-intensity statin therapy on carotid atherosclerotic plaques. METHODS Patients with carotid plaques were recruited to the study from January 2016 to September 2018, and were divided into two groups based on whether or not they were taking statins. All participants underwent 3DUS of their carotid plaques at baseline, then 3 months and 2 years after initial examination. The changes of the carotid plaques were compared between the two groups. RESULTS Were included 97 patients (57 males and 40 females), 65.26 ± 9.53 year-old with 67 into the statin group and 30 in the control group. The baseline levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) were lower in the statin group than in the control group (3.79 ± 0.78 mmol/L vs 4.50 ± 1.12 mmol/L; 2.01 ± 0.62 mmol/L vs 2.58 ± 0.91 mmol/L, P < .05). There was no significant difference in the change of total plaque volume (TPV) detected by 3D-US between the statin (median [interquartile range]: 0 [-30-20] mm3 ) and the control group (0 [-22.5-25] mm3 ) at 3 months. Over 2 years, the TPV increased faster in the control group (+70 [25-150] mm3 ), than in the statin group (15 [-57.5-90) mm3 , P < .05). CONCLUSIONS 3DUS can be an effective tool to observe the development of carotid plaques and the effect of statin treatment.
Collapse
Affiliation(s)
- Yuhui Chen
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| | - Haiying Xing
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| | - Jiexi Wen
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| | - Qing Peng
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| | - Ran Liu
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| | - Wei Sun
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| | - Haiqiang Jin
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| | - Ke Xu
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| | - Yining Huang
- Department of Neurology, Peking University First Hospital, Beijing, China
- Department of Neurology, Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China
| |
Collapse
|
2
|
Calogero E, Fabiani I, Pugliese NR, Santini V, Ghiadoni L, Di Stefano R, Galetta F, Sartucci F, Penno G, Berchiolli R, Ferrari M, Cioni D, Napoli V, De Caterina R, Di Bello V, Caramella D. Three-Dimensional Echographic Evaluation of Carotid Artery Disease. J Cardiovasc Echogr 2018; 28:218-227. [PMID: 30746325 PMCID: PMC6341847 DOI: 10.4103/jcecho.jcecho_57_18] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
The introduction of three-dimensional echography (3D echo) in vascular field is not recent, but it still remains a seldom-used technique because of the costs of ultrasound probe and the need of dedicated laboratories. Therefore, despite significant prognostic implications, the high diagnostic accuracy in plaque definition, and the relative ease of use, 3D echo in vascular field is a niche technique. The purpose of this review is mainly clinical and intends to demonstrate the potential strength of a 3D approach, including technical aspects, in order to present to clinicians and imagers the appealing aspects of a noninvasive and radiation-free methodology with relevant diagnostic and prognostic correlates in the assessment of carotid atherosclerosis. A comprehensive literature search (since 1990s to date) using the PubMed, MEDLINE, and Cochrane libraries databases has been conducted. Articles written in English have been assessed, including reviews, clinical trials, meta-analyses, and interventional/observational studies. Manual cross-referencing was also performed, and relevant references from selected articles were reviewed. The search was limited to studies conducted in humans. Search terms, retrieved also with PubMed Advanced search and AND/OR Boolean operators (mainly in title and abstract), included three-dimensional, echo, stroke/transient ischemic attack, predictors, carotid, imaging, and biomarkers.
Collapse
Affiliation(s)
- Enrico Calogero
- Department of Medical, Surgical, Molecular and Critical Area Pathology, Pisa University, Pisa, Italy.,Department of Cardiac, Thoracic and Vascular, Pisa University, Pisa, Italy
| | - Iacopo Fabiani
- Department of Medical, Surgical, Molecular and Critical Area Pathology, Pisa University, Pisa, Italy.,Department of Cardiac, Thoracic and Vascular, Pisa University, Pisa, Italy
| | - Nicola Riccardo Pugliese
- Department of Medical, Surgical, Molecular and Critical Area Pathology, Pisa University, Pisa, Italy.,Department of Cardiac, Thoracic and Vascular, Pisa University, Pisa, Italy
| | - Veronica Santini
- Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
| | - Lorenzo Ghiadoni
- Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
| | - Rossella Di Stefano
- Department of Medical, Surgical, Molecular and Critical Area Pathology, Pisa University, Pisa, Italy.,Department of Cardiac, Thoracic and Vascular, Pisa University, Pisa, Italy
| | - Fabio Galetta
- Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
| | - Ferdinando Sartucci
- Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
| | - Giuseppe Penno
- Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
| | - Raffaella Berchiolli
- Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University, Pisa, Italy
| | - Mauro Ferrari
- Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University, Pisa, Italy
| | - Dania Cioni
- Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University, Pisa, Italy
| | - Vinicio Napoli
- Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University, Pisa, Italy
| | - Raffaele De Caterina
- Department of Medical, Surgical, Molecular and Critical Area Pathology, Pisa University, Pisa, Italy.,Department of Cardiac, Thoracic and Vascular, Pisa University, Pisa, Italy
| | - Vitantonio Di Bello
- Department of Medical, Surgical, Molecular and Critical Area Pathology, Pisa University, Pisa, Italy.,Department of Cardiac, Thoracic and Vascular, Pisa University, Pisa, Italy
| | - Davide Caramella
- Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University, Pisa, Italy
| |
Collapse
|